
Mary M. Barna, PharmD
Advertisement
Articles by Mary M. Barna, PharmD


Alzheimer's disease represents a mounting public health problem and clinicians need a strong understanding of both the disease and its various treatment modalities.

When discussing overactive bladder disease with a patient, the pharmacist needs to be sensitive to this treatable but often embarrassing medical condition.
Advertisement
Latest Updated Articles
Managing Opioid- Induced ConstipationSeptember 15th 2009
Alzheimer's Disease: Slowing Down the CourseMarch 1st 2009
Overactive Bladder Disease: Overcoming the Urge to GoJanuary 1st 2009
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves First OTC Acetaminophen–Naproxen Combination for 12-Hour Pain Relief
2
FDA Approves Furosemide Autoinjector for Treatment of Edema in CKD or Heart Failure
3
What Real-World Data Show About Moving Patients From Humira to Biosimilars
4
Vaccine Guidance Is Rapidly Changing—Here's What You Need to Know
5